Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Oral bisphosphonates causing adverse effects in therapeutic use

Known as: Oral bisphosphonates 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
SummaryAdherence to oral bisphosphonates is low. A screening strategy is proposed based on the response of biochemical markers of… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2016
Highly Cited
2016
CONTEXT Denosumab and zoledronic acid (ZOL) are parenteral treatments for patients with osteoporosis. OBJECTIVE The objective… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Oral bisphosphonates are first-line therapy for the prevention and treatment of osteoporosis in postmenopausal women. Although… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
SummaryThis database analysis of over 4,000 German women prescribed oral bisphosphonates between December 2004 and November 2007… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
OBJECTIVE To examine the hypothesis that risk of oesophageal, but not of gastric or colorectal, cancer is increased in users of… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
SummaryIn a study of 2005 institutionalized older people, use of oral bisphosphonates was associated with a 27% reduction in risk… Expand
  • table 1
  • table 2
Is this relevant?
2009
2009
BACKGROUND A recent trial unexpectedly reported that atrial fibrillation, when defined as serious, occurred more often in… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2008
2008
OBJECTIVE To determine whether use of oral bisphosphonates is associated with an increased risk of aseptic osteonecrosis (AON… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Context Few studies have evaluated the relative effectiveness of drug therapies for osteoporosis. Contribution This study… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PURPOSE Osteoporosis and osteopenia are characterized by reductions in bone mass and may lead to skeletal fragility and fracture… Expand
  • figure 1
  • table 1
  • figure 2
Is this relevant?